ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Demystifying biologics, their biosimilars and the PBS"
Episode Synopsis
In this episode, Professor Debra Rowett is joined by Professor Andrew Wilson, Chair of the Pharmaceutical Benefits Advisory Committee and Dr Paul Kubler, Consultant Rheumatologist to discuss how b/tsDMARDs are funded in Australia, the policies and mechanisms that influence the cost to government and how the introduction of biosimilars affects the pricing of biologics on the PBS.
More episodes of the podcast ARA Audio Rheum
Down-Titration Living Guidelines
25/02/2021
In God we trust